MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Prostate Cancer Treatment and Research
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

3,880 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
3,880 works in the cohort · of 4,299,418page 15 of 78

Labels cover 13 of 3,880 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 3,880 of 3,880 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
In prostate cancer needle biopsies, detections of PTEN loss by fluorescence in situ hybridization (FISH) and by immunohistochemistry (IHC) are concordant and show consistent association with upgrading
Clarissa Gondim Picanço-Albuquerque, Carlos L. Morais, Filipe L.F. Carvalho, Sarah B. Peskoe, Jessica Hicks, Olga Ludkovski +9 more
2016· article· en· Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin· Medicine
distilled prediction:candidate · noneconsensus · none
39
citations
affno abstractunlabeled
SOX4 is activated by C-MYC in prostate cancer
Hongyan Dong, Jing Hu, Lin Wang, Mei Qi, Ning Lü, Xiao Tan +4 more
2019· article· en· Medical Oncology· Medicine
distilled prediction:candidate · insufficient_payloadconsensus · none
38
citations
affno abstractunlabeled
LBA1 A randomized multicenter open label phase III trial comparing enzalutamide vs a combination of Radium-223 (Ra223) and enzalutamide in asymptomatic or mildly symptomatic patients with bone metastatic castration-resistant prostate cancer (mCRPC): First results of EORTC-GUCG 1333/PEACE-3
Silke Gillessen, Ananya Choudhury, F. Saad, E. Gallardo, André Soares, Y. Loriot +12 more
2024· article· en· Annals of Oncology· Medicine
distilled prediction:candidate · noneconsensus · none
37
citations

How this was built: Screen · Findings · About